The proportion of patients with left atrial enlargement was significantly higher in the AF group (59.8 vs. 18.2%), and the median NT-proBNP levels [784 (IQR 298–1632) vs. 125 (IQR 49–319), p <0.001]. The gene discussed is NPPB; the disease is Left atrial enlargement.